Deloitte’s 2026 Healthcare Outlook shows that while more than two-thirds of U.S. healthcare leaders expect to outperform competitors, rising policy uncertainty is pushing greater focus on digital care ...
More than 50 major insurers have pledged to streamline prior authorization starting in 2026, but providers remain cautiously optimistic and skeptical that the changes will truly reduce burden or ...
As healthcare costs rise, prescription drugs can be one of the costliest aspects of the healthcare experience. In an interview, RxSaveCard CEO and Founder Chris Crawford talked about his new business ...
Rare disease drug developer BioMarin Pharmaceutical is buying its way to revenue growth with a $4.8 billion deal for Amicus Therapeutics, a company whose two commercialized products each offer ...
CMS’ new ACCESS model, slated to begin on July 1, aims to shift traditional Medicare fee-for-service toward value-based care ...
A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb ...
Recent changes to ACIP leadership and vaccine guidance have raised concerns that longstanding immunization protections are ...
The Senate’s rejection of two ACA-focused healthcare bills widened partisan divides and sparked warnings from advocacy groups ...
Texas Attorney General Ken Paxton sued Epic, alleging the company monopolizes the EHR market and restricts access to medical ...
Mark Cuban warned that many employers are collecting drug rebate money funded by their sick employees — a practice that can ...
A group of 13 Democratic House Representatives introduced a package of eight bills last week that would crack down on Medicare Advantage and strengthen traditional Medicare. The package was introduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback